ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,969.34
      0.35%
      US Tech 100
      20,266.40
      0.33%
      Dow Jones
      44,296.51
      0.97%
      Brent Oil
      74.65
      0.00%
      Bitcoin
      98,779.90
      -0.26%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Acrivon Therapeutics Inc (ACRV)

      7. Acrivon Therapeutics Inc (ACRV) Financials

      Acrivon Therapeutics Inc

      Acrivon Therapeutics Inc (ACRV)

      NASDAQ
      6.55
      0.11
      (1.71%)
      Closed November 23 4:00PM
      Delayed by 15 minutes
      6.55
      0.00
      (0.00%)
      After Hours: 4:25PM
      Delayed by 15 minutes

      Acrivon Therapeutics Inc Financial Summary

      The current ACRV market cap is 203.94M. The company's latest EPS is USD -1.9395 and P/E is -3.38.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -15.52M-16.14M-21.05M-17.67M-21.44M
      Net Income -13.91M-14.47M-19.25M-16.49M-18.8M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Total Revenue 000
      Operating Income -16.18M-32.66M-67.1M
      Net Income -16.24M-31.17M-60.39M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)
      Total Assets 160.05M151.09M138.27M120.52M230.59M
      Total Liabilities 10.87M12.94M17.07M12.54M14.53M
      Total Equity 149.18M138.15M121.2M107.98M216.06M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Total Assets 106.59M181.23M138.27M
      Total Liabilities 7.88M10.75M17.07M
      Total Equity -23.81M170.48M121.2M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)
      Operating -20.47M-30.28M-42.64M-17.08M-30.99M
      Investing 28.67M30.18M50.72M5.85M-82.19M
      Financing 379k457k-1.55M-172k123.18M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Operating -13.98M-30.12M-42.64M
      Investing -238k-141.68M50.72M
      Financing 112.22M101.71M-1.55M

      Stats and Ratios

      Market Cap 203.94M
      Price to Earnings Ratio -3.38
      Price to Sales Ratio 0
      Price to Cash Ratio 5.66
      Price to Book Ratio 1.68
      Dividend Yield -

      Share Statistics

      Shares Outstanding 31.14M
      Average Volume (1 week) 57.92k
      Average Volume (1 Month) 47.68k
      52 Week Change 80.44%
      52 Week High 11.90
      52 Week Low 3.19
      Spread (Intraday) 1.91 (22.71%)

      Company Info

      Company Name Acrivon Therapeutics Inc
      Address 838 walker road
      dover, delaware 19904
      Website https://www.acrivon.com
      Industry pharmaceutical preparations (2834)